Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Phenazopyridine hydrochloride (substance) |
Is a |
False |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine measurement (procedure) |
Has measured component |
False |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine measurement (procedure) |
Component |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing phenazopyridine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride (substance) |
Is a |
False |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hyoscyamine- and phenazopyridine- and secbutabarbital-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine- and sulfafurazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine- and sulfamethoxazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Azo-Sulfamethoxazole |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride (substance) |
Is modification of (attribute) |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing phenazopyridine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing oxytetracycline and phenazopyridine and sulfamethizole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing phenazopyridine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing phenazopyridine and sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxytetracycline- and phenazopyridine- and sulfamethizole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only phenazopyridine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only phenazopyridine and sulfafurazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine and sulfamethoxazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only phenazopyridine and sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxytetracycline and phenazopyridine and sulfamethizole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hyoscyamine and phenazopyridine and secbutabarbital only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only phenazopyridine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxytetracycline and phenazopyridine and sulfamethizole only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only phenazopyridine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenazopyridine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |